AI assistant
GlobalSpace Technologies Limited Board/Management Information 2026
61864_rns_2026-05-15_4721a69f-8cd6-4d13-8a5a-1f8122645b9b.pdf
Board/Management Information
Open in viewerOpens in your device viewer
GlobalSpace TECHNOLOGIES
Date: May 15, 2026
To,
The Manager,
BSE Limited
Address: Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai - 400001.
Scrip Code: 540654
Subject: Outcome of Board meeting of the Company held today i.e., Friday, May 15, 2026.
Reference: Regulation 30 read with Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements), 2015 ['Listing Regulations']
Dear Sir/Madam,
This is to inform you that pursuant to Regulation 30 read with Regulation 33 of the Listing Regulations, the Board at its meeting held today i.e., Friday, May 15, 2026, through video Conferencing, inter alia, considered and approved:
1) The Audited Financial results (Standalone and Consolidated) along with the audit Report for the quarter and financial year ended March 31, 2026.
2) The Re-Appointment of M/s. Maheshwari Maheshwari & Co., Practicing Chartered Accountants (FRN: 105838W) as an Internal Auditor of the Company for the financial year 2026-27. (Annexure A)
3) The Appointment of Ms. Tania Mazumdar as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) of the company. (Annexure B)
4) Grant of 4,90,000 Options to the Eligible Employee pursuant to the "Global space Technologies Limited - Employees Stock Options Scheme - 2018".
These intimations are being given pursuant to provisions of Regulation 30 read with Schedule III Part A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 and Details as per SEBI Master Circular bearing no. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are attached as Annexures to this intimation.
The Board Meeting commenced at 04:26 P.M. and concluded at 08:30 P.M.
Kindly take the same on your records.
FOR GLOBALSPACE TECHNOLOGIES LIMITED
KRISHNA
MURARI SINGH
Digitally signed by
KRISHNA MURARI SINGH
Date: 2026.05.15
21:04:27 +05'30'
Krishna Murari Singh
Managing Director
DIN: 03160366
Place: Office No. 605, 6th Floor, Rupa Solitaire Building,
Millennium Business Park, Mahape, Navi Mumbai 400710.
GLOBALSPACE TECHNOLOGIES LIMITED
CIN: L64201MH2010PLC211219
Formerly known as "Globalspace Technologies Private Limited"
Formerly known as "Globalspace Technologies Private Limited"
Regd. Off: Office No. 605, 6th Floor, Rupa Solitaire Building, Millennium Business Park, Mahape, Navi Mumbai 400710
Tel.: 022-49452000 | Email: [email protected] | Website: www.globalspace.in
GlobalSpace TECHNOLOGIES
Annexure A
Details with respect to change in Auditors of the Company as required under Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
| Sr No. | Particular | Details |
|---|---|---|
| 1. | Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise | Re-appointment of M/s. Maheshwari Maheshwari & Co., Practicing Chartered Accountants (FRN: 105838W) as an internal Auditor of the Company for F.Y. 2026-27. |
| 2. | Date of appointment/re-appointment/cessation (as applicable) & term of appointment/re-appointment; | Date of re-appointment -May 15, 2026. |
| Term of re-appointment- re-appointed as an Internal Auditor of the Company for the Financial year 2026-2027. | ||
| 3. | Brief profile (in case of appointment) | Established in 1988, Maheshwari Maheshwari & Co. (MMCO) is a prominent Category-I Chartered Accountancy Firm, headquartered in Mumbai with a branch office in Indore. Over the past 35 years, MMCO has developed a proficient team of partners and professionals, ensuring high-quality service and client satisfaction. It is registered with various regulatory bodies, including ICAI (Reg. No. 105838W), CAG (Reg. No. BO0733), and RBI (Unique Code: 064394), and holds a GST registration number of 27AADFB4406C1Z2. |
| MMCO is led by five partners, each specializing in areas such as statutory audit, internal audit, direct and indirect taxation, litigation support, corporate advisory, IFRS/IND AS implementation, banking, finance, and management consultancy. This diverse expertise allows the firm to offer a comprehensive range of services to its clients, ensuring that they receive the best possible solutions tailored to their needs. | ||
| 4. | Disclosure of relationship between Directors (in case of appointment of a director). | Not Applicable. |
| 5. | Information as required pursuant to BSE circular ref no. LIST/ COMP/ 14/ 201819 and the National Stock Exchange of India Limited with ref no. NSE/CML/2018/24, dated June 20, 2018 | Not Applicable. |
GLOBALSPACE TECHNOLOGIES LIMITED
CIN: L64201MH2010PLC211219
Formerly known as "Globalspace Technologies Private Limited"
Formerly known as "Globalspace Technologies Private Limited"
Regd. Off: Office No. 605, 6th Floor, Rupa Solitaire Building, Millennium Business Park, Mahape, Navi Mumbai 400710
Tel.: 022-49452000 | Email: [email protected] | Website: www.globalspace.in
Annexure B
Details with respect to appointment of Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) of the Company as required under Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
| Sr No. | Particular | Details |
|---|---|---|
| 1. | Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise | Ms. Tania Mazumdar has been appointed as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) of the Company. |
| 2. | Date of appointment/re-appointment/cessation (as applicable) & term of appointment/re-appointment; | Date of appointment -May 15, 2026. |
| Term of appointment- Appointment for the term of 3 (three) years w.e.f. May 15, 2026. | ||
| 3. | Brief profile (in case of appointment) | Dynamic pharmaceutical and digital health leader with 22+ years of experience in driving strategic growth, commercial transformation, and innovation across pharmaceutical, diagnostics, and health technology sectors. Proven expertise in delivering revenue growth, leading high-performance teams, launching digital health solutions, and driving large-scale business initiatives across India and emerging markets. Skilled in strategic planning, business development, commercialization, digital transformation, and stakeholder management, with a strong focus on patient-centric and scalable healthcare solutions. |
| 4. | Disclosure of relationship between Directors (in case of appointment of a director). | Ms. Tania Mazumdar is not related to any director of the Company. |
| 5. | Information as required pursuant to BSE circular ref no. LIST/ COMP/ 14/ 201819 and the National Stock Exchange of India Limited with ref no. NSE/CML/2018/24, dated June 20, 2018 | Not Applicable. |
GLOBALSPACE TECHNOLOGIES LIMITED
CIN: L64201MH2010PLC211219
Regd. Off: Office No. 605, 6th Floor, Rupa Solitaire Building, Millennium Business Park, Mahape, Navi Mumbai 400710
Tel.: 022-49452000 | Email: [email protected] | Website: www.globalspace.in
BANSILAL SHAH & CO.
CHARTERED ACCOUNTANTS
Independent Auditor's Report on the Quarterly and Year to Date Audited Standalone Financial Results of the Company Pursuant to the Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
To
The Board of Directors of
Globalspace Technologies Limited
Report on the audit of the Standalone Financial Results
Opinion
We have audited the accompanying statement of quarterly and year to date standalone financial results of Globalspace Technologies Limited (the "Company") for the quarter ended March 31, 2026 and for the year ended March 31, 2026 ("Statement"), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations").
In our opinion and to the best of our information and according to the explanations given to us, the Statement:
i. is presented in accordance with the requirements of the Listing Regulations in this regard; and
ii. gives a true and fair view in conformity with the applicable accounting standards and other accounting principles generally accepted in India, of the net profit and other comprehensive expense and other financial information of the Company for the quarter ended March 31, 2026 and for the year ended March 31, 2026.
Basis for Opinion
We conducted our audit in accordance with the Standards on Auditing (SAS) specified under section 143(10) of the Companies Act, 2013, as amended ("the Act"). Our responsibilities under those Standards are further described in the "Auditor's Responsibilities for the Audit of the Standalone Financial Results" section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion.
Management's Responsibilities for the Standalone Financial Results
The Statement has been prepared on the basis of the standalone annual financial statements. The Board of Directors of the Company are responsible for the preparation and presentation of the Statement that gives a true and fair view of the net profit and other comprehensive expenses of the Company and other financial information in accordance with the applicable accounting standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 and 52 of the Listing Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate
1027, Hubtown Solaris, N.S. Phadke Marg, Near TeliGali Signal, Andheri-East, Mumbai-400069, Phone No. 022-67410769, Email: [email protected], [email protected]
BANSILAL SHAH & CO.
CHARTERED ACCOUNTANTS
accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Statement that give a true and fair view and are free from material misstatement, whether due to fraud or error.
In preparing the Statement, the Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
The Board of Directors are also responsible for overseeing the Company's financial reporting process.
Auditor's Responsibilities for the Audit of the Standalone Financial Results
Our objectives are to obtain reasonable assurance about whether the Statement as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with SAS will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the Statement.
As part of an audit in accordance with SAS, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the Statement, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
- Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of the Statement, including the disclosures, and whether the Statement represents the underlying transactions and events in a manner that achieves fair presentation.
1027, Hubtown Solaris, N.S. Phadke Marg, Near TeliGali Signal, Andheri-East, Mumbai-400069, Phone No. 022-67410769, Email: [email protected], [email protected]
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
Other Matter
a. The Statement includes the results for the quarter ended March 31, 2026 being the balancing figure between the audited figures in respect of the full financial year ended March 31, 2026 and the published unaudited year-to-date figures up to the third quarter of the current financial year, which were subjected to a limited review by us, as required under the Listing Regulations.
b. Equity Commitment towards M/s Miljon Medi App Pvt Ltd of Rs. 1,144.33 lakhs is pending for share allotment in the books as on 31.03.2026.
For Bansilal Shah & Co.
Chartered Accountants
FRN No: 000384W
Dhruv Shah
Partner
Membership Number 223609
Place: Mumbai
Date: 15th May 2026
UDIN: 26223609RDQPYL2707
GlobalSpace Technologies Limited
Address: 605, Rupa Solitaire Building, Millenium Business Park, Navi Mumbai, Thane - 400710
Tel No : 022-49452015, Email id:- [email protected], website:- www.globalspace.in
Extract of Audited Standalone Financial Results for the quarter and half year ended March 31, 2026
Rs in lacs
| Year end | |||
|---|---|---|---|
| 31-Mar-26 | 31-Mar-25 | ||
| Sr.No | Particulars | Amount | |
| I | ASSETS | ||
| 1 | Non-current assets | ||
| (a) Property, plant and equipment | 406.03 | 393.90 | |
| (b) Intangible assets | 879.89 | 605.85 | |
| (c) Intangible assets under development | 1,369.54 | 354.44 | |
| (d) Financial assets | |||
| (i) Investments | 152.69 | 152.69 | |
| (ii) Other Non Current financial assets | 1,993.32 | 1,890.34 | |
| (i) Deferred tax assets (net) | - | - | |
| (j) Non current tax assets | - | - | |
| (e) Other non current assets | - | - | |
| Total of non current assets | 4,801.47 | 3,397.22 | |
| 2 | Current Assets | ||
| (a) Inventories | 205.48 | 524.89 | |
| (b) Financial assets | |||
| (i) Trade receivables | 232.77 | 597.61 | |
| (ii) Cash and cash equivalents | 0.92 | 3.11 | |
| (iii) Loans | 395.58 | 574.28 | |
| (c) Current Tax Assets (Net) | (13.70) | 116.58 | |
| (d) Other current assets | 889.68 | 1,431.07 | |
| Total Current Assets | 1,710.74 | 3,247.54 | |
| Total assets | 6,512.21 | 6,644.75 | |
| EQUITY AND LIABILITIES | |||
| 3 | Equity | ||
| (a) Equity share capital | 3,436.98 | 3,436.98 | |
| (b) Other equity | 2,151.36 | 2,013.74 | |
| Total equity | 5,588.34 | 5,450.72 | |
| 4 | Liabilities | ||
| Non-current liabilities | |||
| (a) Financial liabilities | |||
| (i) Borrowings | 50.15 | 80.55 | |
| (b) Provisions | 13.63 | 13.02 | |
| (c) Deferred tax liabilities (net) | (20.01) | (32.22) | |
| Total of non current liabilities | 43.77 | 61.35 | |
| 5 | Current Liabilities | ||
| (a) Financial Liabilities | |||
| (i) Borrowings | 279.27 | 888.14 | |
| (ii) Trade payables | |||
| Total outstanding dues of micro enterprises and small enterprises | 331.82 | 7.88 | |
| Total outstanding dues of creditors other than micro enterprises | 139.19 | 106.02 | |
| and small enterprises | - | ||
| (iii) Other financial liabilities | - | - | |
| (b) Other financial liabilities | - | - | |
| (c) Other current liabilities | 129.46 | 130.28 | |
| (d) Provisions | 0.37 | 0.37 | |
| Total liabilities | 880.11 | 1,132.69 | |
| Total equity and liabilities | 6,512.22 | 6,644.74 |
For Bansilal Shah & Co
Chartered Accountants
FRN No : 000384W
Dhruv Shah
Partner
Membership No : 223609
UDIN: 26223609RDQPYL2707
Place: Mumbai
Date: 15/5/2026
For Globalspace Technologies Limited
Krishna Murari Singh
Chairman and Managing Director
DIN: 03160366
Place: Navi Mumbai
Date: 15/5/2026
GlobalSpace Technologies Limited
Address: 605, Rupa Solitaire Building, Millennium Business Park, Navi Mumbai, Thane - 400710
Tel No : 022-49452015, Email id:- [email protected], website:- www.globalspace.in
Extract of Audited Standalone Financial Results for the quarter and year ended March 31, 2026
Rs in lacs
| Particulars | Quarter Ended | Half year ended | Year Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 31-Mar-26 | 31-Dec-25 | 31-Mar-25 | 31-Mar-25 | 30-Sep-25 | 31-Mar-26 | 31-Mar-25 | |||
| (Audited) | (Un-Audited) | (Audited) | Audited | (Un-Audited) | (Audited) | (Audited) | |||
| 1 | INCOME | ||||||||
| Revenue from operation | 1,050.30 | 1,256.85 | 517.62 | 2,307.15 | 994.20 | 3,301.35 | 2,932.48 | ||
| Other Income | 34.28 | - | 0.07 | 34.28 | - | 34.28 | 0.54 | ||
| Total Income | 1,084.58 | 1,256.85 | 517.69 | 2,341.43 | 994.20 | 3,335.63 | 2,933.02 | ||
| 2 | Expenses | ||||||||
| Cost of materials Consumed | 842.23 | 729.56 | 18.73 | 1,571.79 | 494.49 | 2,066.28 | 1,842.49 | ||
| Changes in Inventory of Stock in trade | (26.28) | 251.14 | 26.00 | 224.86 | 94.55 | 319.41 | 52.75 | ||
| Employee Benefits Expenses | 58.41 | 53.84 | 8.96 | 112.25 | 73.84 | 186.09 | 65.99 | ||
| Depreciation and Amortisation Expenses | 37.55 | 38.72 | 45.30 | 76.27 | 84.15 | 160.42 | 202.74 | ||
| Finance Cost | 20.79 | 19.21 | 20.78 | 40.00 | 47.81 | 87.81 | 108.83 | ||
| Other Expenses | 107.97 | 73.82 | 384.99 | 181.79 | 145.24 | 327.03 | 606.05 | ||
| Total Expenses | 1,040.67 | 1,166.29 | 504.77 | 2,206.96 | 940.08 | 3,147.04 | 2,878.85 | ||
| 3 | Profit/Loss Before Exceptional Iteams and tax(1-2) | 43.91 | 90.56 | 12.92 | 134.47 | 54.12 | 188.59 | 54.17 | |
| Exceptional Items | 275.65 | ||||||||
| 4 | Profit/(Loss)before tax | 43.91 | 90.55 | 12.92 | 134.47 | 54.12 | 188.59 | (221.48) | |
| Tax Expense | |||||||||
| Current Tax | (10.73) | 10.73 | 19.98 | 39.88 | |||||
| Deferred Tax | (33.54) | 33.54 | 4.18 | 4.23 | 12.21 | (37.75) | |||
| Total Tax Expenses | (44.27) | 44.27 | 4.18 | 27.89 | 24.21 | 52.10 | (37.75) | ||
| 6 | Net Profit/(Loss) after tax(4-5) | 88.18 | 46.27 | 8.74 | 106.58 | 29.91 | 136.49 | (183.73) | |
| 7 | Other Comprehensive Income | ||||||||
| Items that will not be reclassified into Profit or Loss | 1.13 | (6.41) | 1.13 | 1.13 | (6.41) | ||||
| Total Comprehensive Income | 1.13 | (6.41) | 1.13 | 1.13 | (6.41) | ||||
| 8 | Total Comprehensive Income for the year (after tax)(5+6) | 89.31 | 46.27 | 2.33 | 107.71 | 29.91 | 137.62 | (190.14) | |
| 9 | Less: Share of non controlling Interest | ||||||||
| 10 | Total Comprehensive Income for the year (after tax)(5+6) | 29.91 | |||||||
| 9 | Paid-up Equity Share Capital (Face Value of Re. 10/-each) | 3,436.98 | 3,436.98 | 3,436.98 | 3,436.98 | 3,436.98 | 3,436.98 | 1,145.66 | |
| 10 | Other Equity | 2,151.36 | 2,089.92 | 2,013.74 | 2,151.36 | 2,151.36 | |||
| 11 | Earnings per Equity Share (of Rs. 10/- each) | ||||||||
| Basic | 0.26 | 1.64 | 0.59 | 1.10 | 0.09 | 1.19 | (1.66) | ||
| Diluted | 0.26 | 1.64 | 0.59 | 1.10 | 0.09 | 1.19 | (1.66) |
Notes:
1. The above results were reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting held on May 15, 2026
2. The Statutory auditors have conducted the audit of the financial statements and have expressed an un qualified audit opinion.
3. The Company operates in a single segment. Hence, segment reporting is not applicable.
4. Previous period figures have been re-grouped / re-classified wherever necessary.
For Bansilal Shah & Co
Chartered Accountants
FRN No: 000384W
Dhruv Shah
Partner
Membership No: 223609
UDIN: 26223609RDQPYL2707
Place: Mumbai
For Globalspace Technologies Limited
Krishna Murari Singh
Chairman and Managing Director
DIN: 03160366
Place: Navi Mumbai
Globalspace Technologies Limited
Standalone Cash Flow Statement for the year ended March 31, 2026
(Rs. in lakhs)
| Sl. No. | Particulars | For the year ended March 31, 2026 | For the year ended March 31, 2025 |
|---|---|---|---|
| A | Cash Flow From Operating Activities | ||
| Net profit before tax | 188.59 | (221.46) | |
| Adjustments for: | |||
| Provision for expected credit loss | |||
| Add: Exceptional Items | |||
| Depreciation/amortisation | 160.42 | 202.74 | |
| Interest and finance charges | 87.81 | 108.83 | |
| Profit from sale of Investments | |||
| OCI adjustments | 1.13 | (6.41) | |
| Interest income | |||
| Operating profit before working capital changes | 437.96 | 83.70 | |
| Adjustments: | |||
| Trade receivables | 364.84 | (261.01) | |
| Inventories | 319.41 | 52.75 | |
| Loans | 178.69 | (167.84) | |
| Other current assets/other non current financial assets | 568.69 | (25.79) | |
| Trade payables | 357.11 | 71.66 | |
| Other current liabilities/other current financial liabilities | (0.82) | 51.70 | |
| Provisions | 0.60 | (5.48) | |
| Cash Generated from Operations | 2,226.48 | (200.32) | |
| Taxes paid (net of refunds, if any) | (39.88) | (2.17) | |
| Net cash generated from operating activities (A) | 2,186.59 | (202.49) | |
| - | |||
| Cash Flow From Investing Activities | |||
| Purchase of fixed assets | (1,461.70) | 654.86 | |
| (including intangible assets under development) | |||
| Investment in subsidiary (Sale of shares) | - | (51.95) | |
| Interest income | - | ||
| Net cash (used in ) investing activities (B) | (1,461.70) | 602.91 | |
| - | |||
| Cash Flow From Financing Activities | |||
| Proceeds from share capital | - | - | |
| Share issue expenses | - | ||
| Interest and finance charges | (87.81) | (108.83) | |
| Dividend Paid | |||
| Increase/ (Decrease) in long term borrowings (net) | (30.40) | (50.67) | |
| Increase in short term borrowings (net) | (608.87) | (238.43) | |
| Net cash generated from financing activities (C) | (727.08) | (397.93) | |
| Net (decrease) in cash and cash equivalents (A+B+C) | (2.19) | 2.49 | |
| Cash and cash equivalents at the beginning of the year | 3.11 | 0.62 | |
| Cash and cash equivalents at the end of the year | 0.92 | 3.11 | |
| Net (decrease) as disclosed above | (2.18) | 2.49 |
Notes:
1 The cash flow statement has been prepared under the indirect method as set out in the Ind AS 7 "Statement of Cash Flows"
2 Figures in bracket indicates cash outflow.
3 Components of cash and cash equivalents (closing):
| Particulars | As at March 31, 2026 | As at March 31, 2025 |
|---|---|---|
| Balance with banks in current accounts | 0.92 | 3.11 |
| Total | 0.92 | 3.11 |
The accompanying notes are an integral part of these standalone financial statements
As per report of even date
FRN No: 000384W
Partner
Partner
Membership No : 223609
Place : Mumbai
For and on behalf of the Board of Directors of
Chairman & Managing Director
Ratio Analysis and Its Components
| Particlours | As on 31/3/2026 | As on 31/3/2025 |
|---|---|---|
| 1. Debt-Equity Ratio | 0.06 | 0.18 |
| 2. Debt Service Coverage Ratio | 1.91 | 0.39 |
| 3. Interest Service Coverage Ratio | 4.97 | 0.83 |
| 4. Outstanding Redeemable Preference Shares | N/A | N/A |
| 5. Capital Redemption Reserve/ Debetnures Redemption Reserve | N/A | N/A |
| 6. Net worth | 5,588.34 | 5,450.72 |
| 7. Net profit after tax | 4.13% | -6.27% |
| 8. EPS | 1.19 | 0.03 |
| 9. Current Ratio | 1.94 | 2.87 |
| 10. Long term debt to working capital | 1.94 | 2.87 |
| 11. Bad debts to Accounts receivable ratio | 0.06 | - |
| 12. Current Liability Ratio | 0.95 | 0.95 |
| 13. Total Debt to Total Receivable Ratio | 2.83 | 1.05 |
| 14. Debtors Turnover Ratio | 28.37 | 3.17 |
| 15. Inventory Turnover Ratio | 32.13 | 11.17 |
| 16. Operating Margin | 13% | 12% |
Basis of Ratio
| 2025-26 | 2024-25 | |||||
|---|---|---|---|---|---|---|
| Ratio | Numerator | Denominator | Numerator_ | Denominator_ | Numerator | Denominator |
| Current Ratio | Current Assets | Current Liabilities | 1,710.74 | 880.11 | 3,247.54 | 1,132.69 |
| Debt-Equity Ratio | Total Debt (borrowings) | Total Equity (Equity capital + Reserves & Surplus) | 329.42 | 5,588.34 | 968.69 | 5,450.72 |
| Debt Service Coverage Ratio | EBITA | Finance Cost + Principal Repayment | 436.82 | 228.83 | 90.09 | 228.83 |
| Interest Service Coverage Ratio | EBITA | Interest Expense | 436.82 | 87.81 | 90.09 | 108.83 |
| Inventory turnover ratio | Revenue from operations | Average Inventory {{Opening Inventory + Closing Inventory}/2} | 3,301.35 | 102.74 | 2,932.48 | 262.44 |
| Trade Receivables turnover ratio | Revenue from operations | Average Debtors {{Opening Debtors + Closing Debtors}/2} | 3,301.35 | 116.38 | 2,932.48 | 925.01 |
| Net profit ratio | Net profit after tax | Revenue from operations | 136.49 | 3,301.35 | -183.73 | 2,932.48 |
| Operating Margin | EBIDTA | Revenue from operations | 436.82 | 3,301.35 | 365.74 | 2,932.48 |
| Long term debt to working capital | Long term Debt | Working Capital | 50.15 | 830.63 | 80.55 | 2,114.85 |
| Bad debts to Accounts receivable ratio | Bad Debts | Average Debtors {{Opening Debtors + Closing Debtors}/2} | - | 116.38 | - | 925.01 |
| Current Liability Ratio | Current Liabilities | Total Liabilities | 880.11 | 923.88 | 1,132.69 | 1,194.03 |
| Total Debt to Total Receivable Ratio | Total Debt (borrowings) | Average Debtors {{Opening Debtors + Closing Debtors}/2} | 329.42 | 116.38 | 968.69 | 925.01 |
Notes:
The above results were reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting 1 held on May 15, 2026.
2 The Statutory auditors have conducted the audit of the financial statements and have expressed an un qualified audit opinion.
3 The Group operates in a single segment. Hence, segment reporting is not applicable.
4 Previous period figures have been re-grouped / re-classified wherever necessary.
For Bansilal Shah & Co
Chartered Accountants
Dhruv Shah
Partner
Membership No : 223609
UDIN: 26223609RDQPYL2707
Place: Mumbai
Date : 15/5/2026
Krishna Murari Singh
Chairman and Managing Director
DIN : 03160366
Place: Navi Mumbai
Date : 15/5/2026
Independent Auditor's Report on the Quarterly and Year to Date Consolidated Financial Results of the Company Pursuant to the Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
To
The Board of Directors of
Globalspace Technologies Limited
Report on the audit of the Consolidated Financial Results
Opinion
We have audited the accompanying statement of quarterly and year to date consolidated financial results of Global Technologies Limited ("Holding Company"), its subsidiaries (the Holding Company and its subsidiaries together referred to as "the Group") and its joint venture for the quarter ended March 31, 2026 and for the year ended March 31, 2026 ("Statement"), attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations")
In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of the reports of the other auditors on separate audited financial statements of the subsidiaries and joint venture, the Statement:
i. includes the results of the following entities
| Name of the Entity | Relationship |
|---|---|
| Global Technologies Limited | Holding Company |
| Miljon Medi Private Limites | Subsidiary |
| Innopharma Healthcare Private Limited | Subsidiary |
ii. are presented in accordance with the requirements of the Listing Regulations in this regard; and iii. gives a true and fair view in conformity with the applicable accounting standards, and other accounting principles generally accepted in India, of the consolidated net profit and other comprehensive income/ expense and other financial information of the Group for the quarter ended March 31, 2026 and for the year ended March 31, 2026.
Basis for Opinion
We conducted our audit in accordance with the Standards on Auditing (SAS), as specified under Section 143(10) of the Companies Act, 2013, as amended ("the Act"). Our responsibilities under those Standards are further described in the "Auditor's Responsibilities for the Audit of the Consolidated Financial Results" section of our report. We are independent of the Group and its joint venture in accordance with the 'Code of Ethics' issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics.
We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in "Other Matter" paragraph below, is sufficient and appropriate to provide a basis for our opinion.
Management’s Responsibilities for the Consolidated Financial Results
The Statement has been prepared on the basis of the consolidated annual financial statements. The Holding Company's Board of Directors are responsible for the preparation and presentation of the Statement that give a true and fair view of the net profit and other comprehensive income/ expense and other financial information of the Group including its joint venture in accordance with the applicable accounting standards prescribed under section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 and 52 of the Listing Regulations. The respective Board of Directors of the companies included in the Group and of its joint venture are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of their respective companies and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Statement that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the Statement by the Directors of the Holding Company, as aforesaid.
In preparing the Statement, the respective Board of Directors of the companies included in the Group and of its joint venture are responsible for assessing the ability of their respective companies to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.
The respective Board of Directors of the companies included in the Group and of its joint venture are also responsible for overseeing the financial reporting process of their respective companies.
Auditor’s Responsibilities for the Audit of the Consolidated Financial Results
Our objectives are to obtain reasonable assurance about whether the Statement as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAS will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the Statement.
As part of an audit in accordance with SAS, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the Statement, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.
1027, Hubtown Solaris, N.S. Phadke Marg, Near TeliGali Signal, Andheri-East, Mumbai-400069,
Phone No. 022-67410769, Email: [email protected], [email protected]
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
- Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and its joint venture to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the Statement or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its joint venture to cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of the Statement, including the disclosures, and whether the Statement represent the underlying transactions and events in a manner that achieves fair presentation.
- Obtain sufficient appropriate audit evidence regarding the financial results of the entities within the Group and its joint venture of which we are the independent auditors to express an opinion on the Statement. We are responsible for the direction, supervision and performance of the audit of the financial information of such entities included in the Statement of which we are the independent auditors. For the other entities included in the Statement, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion.
We communicate with those charged with governance of the Holding Company and such other entities included in the Statement of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
We also performed procedures in accordance with the Master Circular issued by the Securities Exchange Board of India under Regulation 33 (8) of the Listing Regulations, to the extent applicable.
Other Matter
The accompanying Statement includes the audited financial statements and other financial information, in respect of:
- Two subsidiaries, whose financial statements are audited by their respective independent auditors are consolidated in the financial statements, the fiancials highlights of the same are as follows:-
BANSILAL SHAH & CO.
CHARTERED ACCOUNTANTS
| Particulars | Net Assets/ (Liabilities) | Revenue | Profit after tax |
|---|---|---|---|
| Innopharm Healthcare Private Limited | |||
| Quarter ended 31st March 2026 | 282.90 | 557.49 | 7.29 |
| Year ended 31st March 2026 | 284.07 | 1855.60 | 23.34 |
| Miljon Medi App Private Limited* | |||
| Quarter ended 31st March 2026 | 178.40 | 0 | 26.99 |
| Year ended 31st March 2026 | 1296.16 | 0 | 25.06 |
- Converted from LLP into Pvt Ltd co as on 31/03/2025
The independent auditor's report on the financial statements of these entities have been furnished to us by the Management and our opinion on the Statement in so far as it relates to the amounts and disclosures included in respect of these subsidiaries and joint venture is based solely on the reports of such auditors and the procedures performed by us as stated in paragraph above.
Our opinion on the Statement is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors.
The Statement includes the results for the quarter ended March 31, 2026 being the balancing figures between the audited figures in respect of the full financial year ended March 31, 2026 and the published unaudited year-to-date figures up to the end of the third quarter of the current financial year, which were subjected to a limited review by us, as required under the Listing Regulations.
For Bansilal Shah & Co.
Chartered Accountants
FRN No: 000384W
Dhruv Shah
Partner
Membership Number 223609
Place: Mumbai
Date: 15th May 2026
UDIN: 26223609OBIQYI9066
GlobalSpace
GlobalSpace Technologies Limited
Address: 605, Rupa Solitaire Building, Millenium Business Park, Navi Mumbai, Thane - 400710
CIN:164201MH2010PLC211219
Tel No : 022-49452015, Email id:- [email protected], website:- www.globalspace.in
Extract of Audited Consolidated Financial Results for the year ended March 31, 2026
| Year end | |||
|---|---|---|---|
| 31-Mar-26 | 31-Mar-25 | ||
| Sr.No | Particulars | Audited | Audited |
| I | ASSETS | ||
| Non-current assets | |||
| (a) Property, plant and equipment | 412.94 | 395.76 | |
| (b) Intangible assets | 1,838.45 | 727.35 | |
| (c) Intangible assets under development | 1,369.54 | 1,216.28 | |
| (d) Right to use | 0.03 | 0.15 | |
| (e) Goodwill | 56.63 | 56.63 | |
| (f) Financial assets | - | ||
| (i) Investments | 100.74 | 100.74 | |
| (ii) Other Non Current financial assets | 779.13 | 796.96 | |
| (iii) Deferred tax assets (net ) | - | ||
| - | |||
| (g) Other non current assets | 2.08 | 2.08 | |
| Total of non current assets | 4,559.56 | 3,295.95 | |
| II | Current Assets | ||
| (a) Inventories | 205.48 | 524.89 | |
| (b) Financial assets | |||
| (i) Trade receivables | 452.28 | 816.16 | |
| (ii) Cash and cash equivalents | 15.23 | 28.55 | |
| (iii) Loans | 436.48 | 494.95 | |
| (c) Current Tax Assets (Net) | 51.40 | 151.77 | |
| (d) Other current assets | 957.14 | 1,493.95 | |
| Total Current Assets | 2,118.01 | 3,510.27 | |
| Total assets | 6,677.56 | 6,806.21 | |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| (a) Equity share capital | 3,436.98 | 3,436.98 | |
| (b) Other equity | 2,258.02 | 1,989.39 | |
| (c) Non Controlling Interest | - | ||
| (d) Capital reserve on consolidation | |||
| Total equity | 5,695.00 | 5,426.37 | |
| III | Liabilities | ||
| Non-current liabilities | |||
| (a) Financial liabilities | |||
| (i) Borrowings | 50.15 | 80.55 | |
| and small enterprises | |||
| (b) Provisions | 12.39 | ||
| (c) Deferred tax liabilities (net) | (178.41) | (40.23) | |
| (d) Minority Interest | 81.77 | 64.06 | |
| Total of non current liabilities | (34.11) | 104.39 | |
| IV | Current Liabilities | ||
| (a) Financial Liabilities | |||
| (i) Borrowings | 279.27 | 888.14 | |
| (ii) Trade payables | - | ||
| Total outstanding dues of micro enterprises and small enterprises | 316.18 | 100.06 | |
| Total outstanding dues of creditors other than micro enterprises | 190.33 | 73.84 | |
| and small enterprises | - | ||
| (iii) Other financial liabilities | - | ||
| (b) Other financial liabilities | |||
| (c) Other current liabilities | 205.49 | 199.75 | |
| (d) Provisions | 25.41 | 13.67 | |
| Total liabilities | 1,016.68 | 1,275.47 | |
| - | |||
| Total equity and liabilities | 6,677.57 | 6,806.22 |
FRN No : 000384W
Partner
UDIN: 26223609OBIQYI9066
Date : 15/5/2026
GlobalSpace
GlobalSpace Technologies Limited
Extract of Audited Consolidated Financial Results for the quarter and year ended March 31, 2026
| Particulars | Quarter Ended | Half year ended | Year Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 31-Mar-26 | 31-Dec-25 | 31-Mar-25 | 31-Mar-26 | 30-Sep-25 | 31-Mar-26 | 31-Mar-25 | |||
| (Audited) | (Un-Audited) | (Audited) | Audited | (Un-Audited) | (Audited) | (Audited) | |||
| 1 | INCOME | ||||||||
| Revenue from operation | 1,604.49 | 1,663.50 | 875.13 | 3,267.99 | 1,878.93 | 5,146.92 | 4,304.58 | ||
| Other Income | 36.88 | 0.75 | 0.77 | 37.63 | 1.55 | 39.18 | 4.59 | ||
| Total Income | 1,641.37 | 1,664.25 | 875.90 | 3,305.62 | 1,880.48 | 5,186.10 | 4,309.17 | ||
| 2 | Expenses | ||||||||
| Cost of materials Consumed | 838.93 | 722.83 | 6.91 | 1,561.76 | 494.49 | 2,056.25 | 1,830.67 | ||
| Changes in Inventory of Stock in trade | (26.28) | 251.14 | 26.00 | 224.86 | 94.55 | 319.41 | 52.75 | ||
| Employee Benefits Expenses | 433.27 | 309.11 | 94.78 | 742.38 | 637.56 | 1,379.94 | 937.18 | ||
| Depreciation and Amortisation Expenses | 45.29 | 45.17 | 76.08 | 90.46 | 96.75 | 187.21 | 234.72 | ||
| Finance Cost | 21.38 | 19.21 | 20.82 | 40.59 | 47.81 | 88.40 | 108.86 | ||
| Other Expenses | 281.45 | 222.61 | 668.70 | 504.06 | 455.66 | 959.72 | 1,111.83 | ||
| Total Expenses | 1,594.04 | 1,570.07 | 893.28 | 3,164.11 | 1,826.82 | 4,990.93 | 4,276.00 | ||
| 3 | Profit/Loss Before Exceptional Items and tax(1-2) | 47.33 | 94.18 | (17.38) | 141.51 | 53.66 | 195.17 | 33.17 | |
| Exceptional Items | - | - | - | - | - | - | 275.65 | ||
| 4 | Profit/(Loss)before tax | 47.33 | 94.18 | (17.38) | 141.51 | 53.66 | 195.17 | (242.48) | |
| Tax Expense | |||||||||
| Current Tax | 12.04 | 13.09 | 1.37 | 25.13 | 23.00 | 48.13 | 2.59 | ||
| Deferred Tax | (209.76) | 44.87 | (3.27) | (164.89) | 26.70 | (138.19) | (45.15) | ||
| Total Tax Expenses | (197.71) | 57.96 | (1.91) | (139.75) | 49.70 | (90.05) | (42.56) | ||
| 6 | Net Profit/(Loss) after tax(4-5) | 245.05 | 36.22 | (15.48) | 281.27 | 3.96 | 285.23 | (199.92) | |
| 7 | Other Comprehensive Income | ||||||||
| Items that will not be reclassified into Profit or Loss | 1.62 | (6.14) | 1.62 | (0.50) | 1.12 | (6.41) | |||
| Total Comprehensive Income | 1.62 | (6.14) | 1.62 | (0.50) | 1.12 | (6.41) | |||
| Less: Share of minority | 14.14 | 3.57 | 8.15 | 17.71 | 17.71 | 8.15 | |||
| 8 | Total Comprehensive Income for the year (after tax)(5+6) | 232.53 | 32.65 | (30.04) | 265.18 | 3.46 | 268.64 | (214.48) | |
| 9 | Less: Share of non controlling Interest | (1.24) | (1.24) | 1.24 | |||||
| 10 | Total Comprehensive Income for the year (after tax)(5+6) | 233.77 | 32.65 | (30.04) | 266.42 | 2.22 | 268.64 | (214.48) | |
| 9 | Paid-up Equity Share Capital (Face Value of Re. 10 /- each) | 3,436.98 | 3,436.98 | 3,436.98 | 3,436.98 | 1,145.66 | 3,436.98 | 3,436.98 | |
| 10 | Other Equity | 2,258.02 | 2,023.31 | 2,203.86 | 2,258.02 | 1,951.84 | 2,258.02 | 1,989.39 | |
| 11 | Earnings per Equity Share (of Rs. 10/- each) | ||||||||
| Basic | 0.68 | 0.20 | (4.14) | 4.69 | (2.20) | 2.49 | (1.75) | ||
| Diluted | 0.68 | 0.20 | (4.14) | 4.69 | (2.20) | 2.49 | (1.75) |
Notes:
1 The above results were reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting held on May 15, 2026
2 The Statutory auditors have conducted the audit of the financial statements and have expressed an un qualified audit opinion.
3 Segment result as per IND-AS-108 is disclosed separately
4 Previous period figures have been re-grouped / re-classified wherever necessary.
Ohruv Shah
Membership No: 223609
UDIN: 26223609OBQY9066
Extract of Audited Consolidated Financial Results for the year ended March 31, 2026
Cash Flow Statement
Rs in lacs
| Sl. No. | Particulars | For the half year ended March 31, 2026 Audited | For the year ended March 31, 2025 Audited |
|---|---|---|---|
| A | Cash Flow From Operating Activities | ||
| Net profit before tax | 195.17 | 33.17 | |
| Adjustments for: | |||
| Provision for expected credit loss | - | - | |
| Exceptional items | - | (275.65) | |
| Depreciation/amortisation | 187.21 | 234.72 | |
| Interest and finance charges | 88.40 | 108.86 | |
| Loss From sale of Investment | - | - | |
| Profit from sale of Investments | 1.12 | (8.57) | |
| OCI adjustments | - | - | |
| Interest income | - | - | |
| Operating profit before working capital changes | 471.91 | 92.53 | |
| Adjustments: | - | ||
| Trade receivables | 363.89 | (479.56) | |
| Inventories | 319.41 | 52.75 | |
| Loans | 58.47 | (69.40) | |
| Bank balances other cash and cash equivalents | - | - | |
| Other current assets/other non current financial assets | 655.01 | 1,002.63 | |
| Trade payables | 332.60 | 131.66 | |
| Other current liabilities/other current financial liabilities | 5.74 | 121.18 | |
| Provisions | 24.12 | (5.20) | |
| Cash Generated from Operations | 2,231.14 | 846.59 | |
| Taxes paid (net of refunds, if any) | (48.13) | (57.51) | |
| Net cash generated from operating activities (A) | 2,183.01 | 789.08 | |
| Cash Flow From Investing Activities | - | ||
| Purchase of fixed assets | (1,468.64) | (419.10) | |
| Investment in subsidiary (Sale of shares) | - | - | |
| Interest income | - | - | |
| Net cash (used in ) investing activities (B) | (1,468.64) | (419.10) | |
| C | Cash Flow From Financing Activities | ||
| Proceeds from share capital | - | - | |
| Share issue expenses | - | 55.91 | |
| Interest and finance charges | (88.40) | (108.86) | |
| Increase in long term borrowings (net) | (30.40) | (50.67) | |
| Increase in short term borrowings (net) | (608.87) | (238.43) | |
| Net cash generated from financing activities (C) | (727.68) | (342.06) | |
| Net (decrease) in cash and cash equivalents (A+B+C) | (13.31) | 27.92 | |
| Cash and cash equivalents at the beginning of the year | 28.55 | 0.62 | |
| Cash and cash equivalents at the end of the year | 15.23 | 28.55 |
UDIN: 26223609OBEQY0066
For Globalspace Technology
Ratio Analysis and Its Components
| Participants | As on 31/3/2026 | As on 31/3/2025 |
|---|---|---|
| 1. Debt-Equity Ratio | 0.06 | 0.18 |
| 2. Debt Service Coverage Ratio | 5.33 | 0.93 |
| 3. Interest Service Coverage Ratio | 5.33 | 0.93 |
| 4. Outstanding Redeemable Preference Shares | N/A | N/A |
| 5. Capital Redemption Reserve/ Debetnures Redemption Reserve | N/A | N/A |
| 6. Net worth | 5,695.00 | 5,426.37 |
| 7. Net profit after tax | 5.54% | -4.64% |
| 8. EPS | 2.49 | (1.75) |
| 9. Current Ratio | 2.08 | 2.75 |
| 10. Long term debt to working capital | 2.08 | 2.75 |
| 11. Bad debts to Accounts receivable ratio | 0.06 | 0.18 |
| 12. Current Liability Ratio | 1.03 | 0.92 |
| 13. Total Debt to Total Receivable Ratio | 0.52 | 1.68 |
| 14. Debtors Turnover Ratio | 8.12 | 7.47 |
| 15. Inventory Turnover Ratio | 50.10 | 7.19 |
| 16. Operating Margin | 9% | 9% |
Basis of Ratio
| 2025-26 | 2024-25 | |||||
|---|---|---|---|---|---|---|
| Ratio | Numerator | Denominator | Numerator | Denominator | Numerator | Denominator |
| Current Ratio | Current Assets | Current Liabilities | 2,118.01 | 1,016.68 | 3,510.27 | 1,275.47 |
| Debt-Equity Ratio | Total Debt (borrowings) | Total Equity (Equity capital + Reserves & Surplus) | 329.42 | 5,695.00 | 968.69 | 5,426.37 |
| Debt Service Coverage Ratio | EBITA | Finance Cost + Principal Repayment | 470.79 | 88.40 | 101.10 | 108.86 |
| Interest Service Coverage Ratio | EBITA | Interest Expense | 470.79 | 88.40 | 101.10 | 108.86 |
| Inventory turnover ratio | Revenue from operations | Average Inventory ((Opening inventory + Closing inventory)/2) | 5,146.92 | 102.74 | 4,304.58 | 598.48 |
| Trade Receivables turnover ratio | Revenue from operations | Average Debtors ((Opening Debtors + Closing Debtors)/2) | 5,146.92 | 634.22 | 4,304.58 | 576.38 |
| Net profit ratio | Net profit after tax | Revenue from operations | 285.23 | 5,146.92 | -199.92 | 4,304.58 |
| Operating Margin | EBIDTA | Revenue from operations | 470.79 | 5,146.92 | 376.75 | 4,304.58 |
| Long term debt to working capital | Long term Debt | Working Capital | 50.15 | 1,101.33 | 80.55 | 2,234.80 |
| Bad debts to Accounts receivable ratio | Bad Debts | Average Debtors ((Opening Debtors + Closing Debtors)/2) | - | 634.22 | 576.38 | |
| Current Liability Ratio | Current Liabilities | Total Liabilities | 1,016.68 | 982.56 | 1,275.47 | 1,379.85 |
| Total Debt to Total Receivable Ratio | Total Debt (borrowings) | Average Debtors ((Opening Debtors + Closing Debtors)/2) | 329.42 | 634.22 | 968.69 | 576.38 |
Dhru Shah
UDIN: 262236090000219066
Extract of Consolidated Segment results for Financial Results for the quarter and year ended March 31, 2026
| Particulars | Quarter Ended | Year Ended | |||
|---|---|---|---|---|---|
| 31-Mar-26 | 31-Dec-25 | 31-Mar-25 | 31-Mar-26 | 31-Mar-25 | |
| (Audited) | (Un-Audited) | (Audited) | (Audited) | (Audited) | |
| Segment Value of Sales and Services (Revenue) | |||||
| Global | 1,050.30 | 1,256.85 | 517.62 | 3,301.35 | 2,932.48 |
| Innopharm | 557.49 | 1,298.11 | 369.33 | 1,855.60 | 1,383.92 |
| Others | |||||
| Less: Inter Segment Transfers | 2.11 | 10.03 | 11.82 | ||
| Revenue from Operation | 1,605.69 | 2,554.96 | 886.95 | 5,146.92 | 4,304.58 |
| Segment Results (Profit before interest and tax) | |||||
| Global | 38.46 | 109.76 | 33.70 | 276.40 | (112.63) |
| Innopharm | 10.51 | 21.72 | 0.65 | 32.23 | 9.93 |
| Others | (41.65) | (30.91) | (41.65) | (30.91) | |
| Total Segment Profit (Profit before interest an | 7.32 | 131.48 | 3.44 | 266.99 | (133.61) |
| Total Segment Profit before Interest.and Tax | |||||
| (i) Finance Cost | 16.80 | 19.21 | 20.78 | 88.40 | 108.86 |
| (ii) Interest Income | - | ||||
| (iii) Other Un-allocable Iricome (Net of Expenditure) | - | ||||
| Profit Before Tax | (9.48) | 112.27 | (17.34) | 178.58 | (242.47) |
| (i) Current Tax | 12.04 | 13.09 | 1.37 | 48.13 | 2.59 |
| (ii) Deferred Tax | (209.76) | 44.87 | (3.27) | (138.19) | (45.15) |
| Profit After Tax | 188.23 | 54.31 | (15.44) | 268.64 | (199.91) |
| Segment Assets | |||||
| Global | 5,266.69 | 6,644.76 | |||
| Innopharm | 283.62 | 264.18 | |||
| Others | 1,138.20 | 1,162.31 | |||
| Eliminations | (1,245.40) | (1,265.02) | |||
| Total Segment Asset | 5,443.11 | 6,806.23 | |||
| Segment Liabilities | |||||
| Global | 942.56 | 1,194.03 | |||
| Innopharm | 131.83 | 135.73 | |||
| Others | (157.96) | 1,255.74 | |||
| Eliminations | (1,245.40) | (1,265.02) | |||
| Total Segment Liabilities | (328.96) | 1,320.48 |
A